COLO B
vs
O
OMX Copenhagen 25
COLO B
Over the past 12 months, COLO B has underperformed OMX Copenhagen 25, delivering a return of -34% compared to the OMX Copenhagen 25's 5% drop.
Stocks Performance
COLO B vs OMX Copenhagen 25
Performance Gap
COLO B vs OMX Copenhagen 25
Performance By Year
COLO B vs OMX Copenhagen 25
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Coloplast A/S
Glance View
Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.
